Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9HA64
UPID:
KT3K_HUMAN
Alternative names:
Fructosamine-3-kinase-related protein; Protein-psicosamine 3-kinase FN3KRP
Alternative UPACC:
Q9HA64; Q969F4; Q9H0U7
Background:
Ketosamine-3-kinase, also known as Fructosamine-3-kinase-related protein or Protein-psicosamine 3-kinase FN3KRP, plays a crucial role in protein deglycation. It mediates the phosphorylation of ribuloselysine and psicoselysine on glycated proteins, producing ribuloselysine-3 phosphate and psicoselysine-3 phosphate. These adducts are unstable and decompose under physiological conditions, highlighting the enzyme's role in maintaining protein integrity by reversing glycation damage.
Therapeutic significance:
Understanding the role of Ketosamine-3-kinase could open doors to potential therapeutic strategies. Its involvement in protein deglycation suggests a fundamental role in cellular health and the prevention of glycation-related pathologies.